Hypoglycemic effects of a beta-agonist, Ro 16-8714, in streptozotocin-diabetic rats: decreased hepatic glucose production and increased glucose utilization in oxidative muscles.
Ferré, P
Hypoglycemic effects of a beta-agonist, Ro 16-8714, in streptozotocin-diabetic rats: decreased hepatic glucose production and increased glucose utilization in oxidative muscles. [electronic resource] - Metabolism: clinical and experimental Feb 1992 - 180-3 p. digital
Publication Type: Journal Article
0026-0495
10.1016/0026-0495(92)90149-5 doi
2-Hydroxyphenethylamine--analogs & derivatives
3-Hydroxybutyric Acid
Adrenergic beta-Agonists--therapeutic use
Animals
Diabetes Mellitus, Experimental--drug therapy
Fatty Acids, Nonesterified--blood
Glucose--metabolism
Glycosuria
Hydroxybutyrates--blood
Hypoglycemic Agents--therapeutic use
Kinetics
Lactates--blood
Liver--drug effects
Muscles--drug effects
Rats
Rats, Inbred Strains
Reference Values
Hypoglycemic effects of a beta-agonist, Ro 16-8714, in streptozotocin-diabetic rats: decreased hepatic glucose production and increased glucose utilization in oxidative muscles. [electronic resource] - Metabolism: clinical and experimental Feb 1992 - 180-3 p. digital
Publication Type: Journal Article
0026-0495
10.1016/0026-0495(92)90149-5 doi
2-Hydroxyphenethylamine--analogs & derivatives
3-Hydroxybutyric Acid
Adrenergic beta-Agonists--therapeutic use
Animals
Diabetes Mellitus, Experimental--drug therapy
Fatty Acids, Nonesterified--blood
Glucose--metabolism
Glycosuria
Hydroxybutyrates--blood
Hypoglycemic Agents--therapeutic use
Kinetics
Lactates--blood
Liver--drug effects
Muscles--drug effects
Rats
Rats, Inbred Strains
Reference Values